期刊文献+

64层螺旋CT肾动脉造影中使用低剂量对比剂的可行性研究 被引量:4

Feasibility of Low Dose Contrast Agent in Renal Artery Angiography Using 64-slice Spiral CT
原文传递
导出
摘要 目的探讨64层螺旋CT肾动脉造影中使用低剂量对比剂的可行性。资料与方法60例临床疑有肾动脉病变患者按随机分类法分成3个使用不同剂量对比剂组(2.0ml/kg体重、1.5ml/kg体重、1.0ml/kg体重),每组20例,而后行64层螺旋CT肾动脉造影检查。每组分别测量腹主动脉及双侧肾动脉CT值进行比较;对图像按优、良、差作3级评价。结果3组腹主动脉及双侧肾动脉CT值均>200HU,差异无统计学意义。肾动脉显像在3组病例中均能达到优或良,合计优良率均为100%(20/20),图像评分上3组间差异也无统计学意义。结论64层螺旋CT肾动脉造影中,使用低剂量对比剂可以获得满意的肾动脉图像,同时也可减轻患者经济负担,减少对比剂对肾功能的影响。 Objective To investigate the feasibility of low dose contrast medium in renal artery CT angiography(CTA) using 64-slice spiral CT.Materials and Methods 60 patients suspected with renal artery lesions performed renal artery CTA.The patients were randomly divided into three groups with 20 patients each according to the contrast medium dosage of 2.0 ml/kg,1.5 ml/kg,and 1.0 ml/kg.CT attenuation values of the abdominal aortic artery(AAA) and bilateral renal artery(RA) were measured and the image qualities were evaluated and recorded as excellent,good,and poor for each group.Results CT attenuation values of both the AAA and RA were over 200 HU,and there was no significant difference among the three groups.The image qualities of RA in three groups were well delineated as excellent or good and also there was no significant difference.Conclusion It is feasible to use low dose contrast medium in 64-slice spiral CTA for the renal arteries.It may reduce the patients' expenses and the potential risk of contrast nephropathy.
出处 《临床放射学杂志》 CSCD 北大核心 2009年第9期1287-1289,共3页 Journal of Clinical Radiology
关键词 体层摄影术 X线计算机 血管造影术 肾动脉 Tomography X-ray computed Angiography Renal artery
  • 相关文献

参考文献10

  • 1Pannu HK, Fishnm EK. Muhidetector computed tomographic evaluation of the renal artery. Abdom imaging,2002,27:611.
  • 2Persson PB ,Tepel M. Contrast medium-induced nephropathy :the pathophysiology (Review). Kidney Int Suppl,2006,69 :8.
  • 3Wong GT, Irwin MG. Contrast-induced nephropathy. Br J Anaesth, 2007,99:474.
  • 4张龙江,祁吉.对比剂肾病:一个值得关注的问题[J].中华放射学杂志,2007,41(8):882-884. 被引量:69
  • 5Al-Ghonaim M, Pannu N. Prevention and treatment of contrast-induced nephropathy. Tech Vase Interv Radiol,2006,9:42.
  • 6Katzberg RW,Haller C. Contrast-induced nephrotoxicity:clinical landscape (Review). Kidney Int Suppl,2006 ,69 :3.
  • 7Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy ( Review). AJR ,2004,183 : 1673.
  • 8刘玉春,杨福燕,胡桂才,王海燕.低渗非离子型造影剂对肾功能影响的前瞻性研究[J].中华内科杂志,2001,40(11):733-736. 被引量:27
  • 9Foley WD, Karcaaltincaba M. Compuled tomography angiography :principies and clinical applications. JCAT,2003,1:23.
  • 10Brink JA. Contrast optimization and scan timing for single and multidetector-row computed tomography. JCTA ,2003,1:3.

二级参考文献24

  • 1Wang A,Kidney Int,2000年,57卷,1675页
  • 2Rudnick M R,Semin Nephrol,1997年,17卷,15页
  • 3Heinrich MC, Kuhlmann MK, Grgic A, et al. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro. Radiology, 2005,235 : 843 -849.
  • 4Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.J Am Coll Cardiol,2004,44 : 1393-1399.
  • 5Pannu N, Wiebe N, Tonelli M, et al. Alberta kidney disease network, prophylaxis strategies for contrast-induced nephropathy (Review). JAMA ,2006,295:2765-2779.
  • 6Briguofi C, Marenzi G. Contrast-induced nephropathy:pharmacological prophylaxis (Review). Kidney Int Suppl,2006, 69 : S30-S38.
  • 7Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med ,2000 ,343 : 180-184.
  • 8Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med ,2006,354:2773-2782.
  • 9Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape (Review). Kidney Int Suppl,2006 ,69 : S3-S7.
  • 10Persson PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology (Review). Kidney Int Suppl,2006,69 : S8 -S10.

共引文献92

同被引文献51

  • 1孙培钰(综述),朱建华(审校).造影剂肾病的危险因素及防治进展[J].国际泌尿系统杂志,2007,27(4):559-562. 被引量:5
  • 2张龙江,祁吉.对比剂肾病:一个值得关注的问题[J].中华放射学杂志,2007,41(8):882-884. 被引量:69
  • 3Wong GT, Irwin MG. Contrast-induced nephropathy. Br J Anaesth, 2007.99:474.
  • 4Schweiger MJ, Chambers CE, Davidson CJ, et at. Prevention of contrast induced nephropathy:recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv, 2007,69 : 135.
  • 5Takamura Y,Tanooka A, Morimoto S, et al. Usefulness of three-dimensional CT angiography with a single bolus injection of contrast material for the examination of intracranial and cervical arteries in cerebrovascular disease screening. No Shinkei Geka,2001,29 :401.
  • 6Loutrianakis E, Stella D, hussain A, et al. Randomized comparison of fenaldopam and nacetylcysteine to saline in the prevention of radiocontrast nephropathy. J AM Coll Card,2003,41:327.
  • 7Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract,2003 ,93 :29.
  • 8Call J, Sacrinty M, Applegate R, et al. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. Invasive Cardiol, 2006,18 : 469.
  • 9Davidson C, Stacul F, McCullough PA, et al. CIN Consensus Working Panel. Contrast medium use. Am J Cardiol,2006,98:42.
  • 10Schweiger MJ,Chambers CE,Davidson CJ,et al.Prevention of con-trast induced nephropathy:recommendations for the high risk pa-tient undergoing cardiovascular procedures [J].Catheter CardiovascInterv,2007,69(1):135-140.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部